NAMPT and cancer: High levels of circulating visfatin are reportedly significantly associated with the risk of cancer 41, while higher plasma visfatin levels have been reported in male patients with OSCC, independently of risk factors, which suggests that visfatin is an important contributor to the pathogenesis of OSCC 12.